Table of Contents
Investors who experienced losses in Telix Pharmaceuticals Ltd. (NASDAQ:TLX) between February 21, 2025, and August 28, 2025, may be eligible to recover their losses through a recently filed class action lawsuit.
New York, NY – November 29, 2025 – A securities fraud class action lawsuit has been filed against Telix Pharmaceuticals Ltd., alleging that the company misled investors regarding key aspects of its business. The suit, announced today by Levi & Korsinsky, LLP, seeks to recover damages for shareholders adversely affected by these alleged misrepresentations.
Allegations of Misleading Statements
The complaint centers around claims that Telix Pharmaceuticals made false and/or concealed material information concerning several critical areas. Specifically, the lawsuit alleges that the company materially overstated the progress it had achieved in developing therapeutic candidates for prostate cancer. Furthermore, the suit claims that Telix materially overstated the quality of its supply chain and partnerships.
According to the filing, these inaccuracies led to statements about Telix’s business, operations, and future prospects that were ultimately false and misleading, lacking a reasonable basis in fact.
What Investors Can Do
Investors who purchased Telix Pharmaceuticals stock during the period between February 21, 2025, and August 28, 2025, are encouraged to explore their legal options. Even those who continue to hold their shares may be entitled to a recovery.
Levi & Korsinsky, LLP, is offering a no-cost consultation to potential plaintiffs. Interested parties can learn more and submit their information through an online form: https://zlk.com/pslra-1/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=179329&wire=1&utm_campaign=15. Alternatively, investors can contact Joseph E. Levi, Esq. directly via email at [email protected] or by phone at (212) 363-7500.
Levi & Korsinsky: A Leading Securities Litigation Firm
Levi & Korsinsky LLP has established a strong reputation in the field of securities litigation over the past two decades. The firm has reportedly secured hundreds of millions of dollars for shareholders and boasts a proven track record in high-stakes cases. With a team of over 70 employees, Levi & Korsinsky provides extensive expertise in representing investors in complex securities litigation.
For seven consecutive years, the firm has been recognized by ISS Securities Class Action Services, ranking among the Top 50 securities litigation firms in the United States.
“We are dedicated to advocating for investors who have been harmed by corporate misconduct,” stated a representative from Levi & Korsinsky.
Contact Information
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/
Please note: This information is for informational purposes only and does not constitute legal advice. This is attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
